STOCK TITAN
  1. Home
  2. Sec-filings
  3. NVAX
  4. [Form 4] NOVAVAX INC Insider Trading Activity

Equity awards to Novavax (NVAX) director: 14,180 RSUs and 21,270 options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Novavax director John W. Shiver received new equity awards as part of his board compensation. On June 18, 2026, he was granted 14,180 restricted stock units, each representing one share of Novavax common stock. He was also granted stock options on 21,270 shares at an exercise price of $9.13 per share.

Both the RSUs and the options were awarded under Novavax’s Amended and Restated 2015 Stock Incentive Plan. According to the terms, all of the shares subject to each grant vest on the first anniversary of the June 18, 2026 grant date, if he continues serving on the board through that date.

Positive

  • None.

Negative

  • None.
Insider Shiver John W.
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 21,270 $0.00 --
Grant/Award Restricted Stock Units 14,180 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 21,270 shares (Direct, null); Restricted Stock Units — 14,180 shares (Direct, null)
Footnotes (1)
  1. One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
RSU grant size 14,180 units Restricted Stock Units granted June 18, 2026
Option grant size 21,270 options Stock Option (Right to Buy) granted June 18, 2026
Option exercise price $9.13 per share Conversion or exercise price for stock options
Option expiration June 18, 2036 Expiration date of stock options
RSUs following transaction 14,180 units Total RSUs held after grant
Options following transaction 21,270 options Total options held after grant
Restricted Stock Units financial
"security_title: "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Amended and Restated 2015 Stock Incentive Plan financial
"shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended"
restricted stock unit ("RSU") financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Shiver John W.
(Last)(First)(Middle)
21 FIRSTFIELD ROAD
(Street)
GAITHERSBURG MARYLAND 20878
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
NOVAVAX INC [ NVAX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$9.1306/18/2026A21,270 (1)06/18/2036Common Stock21,270$021,270D
Restricted Stock Units(2)06/18/2026A14,180 (3) (3)Common Stock14,180$014,180D
Explanation of Responses:
1. One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.
3. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
/s/ Mark J. Casey, Attorney-in-Fact06/23/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What does the latest Novavax (NVAX) Form 4 filing report for John W. Shiver?

The Form 4 shows Novavax director John W. Shiver received equity compensation grants. He was awarded 14,180 restricted stock units and stock options on 21,270 shares, reflecting routine board compensation rather than open-market stock purchases or sales.

How many RSUs did Novavax (NVAX) grant to director John W. Shiver?

Novavax granted John W. Shiver 14,180 restricted stock units. Each RSU represents a right to receive one share of Novavax common stock, subject to vesting based on his continued service on the company’s board of directors through the specified vesting date.

What stock options were granted to John W. Shiver in the Novavax (NVAX) Form 4?

Shiver received stock options covering 21,270 shares of Novavax common stock with an exercise price of $9.13 per share. These options were granted under the company’s 2015 Stock Incentive Plan and have an expiration date of June 18, 2036, subject to vesting conditions.

Are the Novavax (NVAX) Form 4 transactions open-market buys or sells?

The reported transactions are not open-market buys or sells. They are compensation-related equity awards: grants of restricted stock units and stock options to a director, classified as acquisitions under transaction code “A” rather than purchases or sales in the open market.

How do the Novavax (NVAX) RSU and option grants to John W. Shiver vest?

Both the RSU and option grants are scheduled to vest 100% on the first anniversary of the June 18, 2026 grant date. Vesting is conditioned on Shiver’s continued service on Novavax’s board of directors through that one-year vesting date under the plan terms.

Under which plan were John W. Shiver’s Novavax (NVAX) equity awards granted?

The RSUs and stock options were granted under Novavax’s Amended and Restated 2015 Stock Incentive Plan, as amended. This plan governs the terms of the awards, including vesting schedules, exercise price for options, and service requirements for directors receiving equity compensation.